The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

Original “Little House on the Prairie” star Melissa Gilbert fired back at Megyn Kelly over a comment the former Fox News host ...

President Donald Trump on Saturday finalized tariffs, set to go into effect on Tuesday, at 10 percent on all Chinese goods, ...

Hours before fire-ravaged Pacific Palisades was set to reopen to the public, Los Angeles Mayor Karen Bass reversed course on the controversial decision, saying Saturday night that the checkpoints ...

2024年12月中美欧批准上市新药盘点我国批准16款新药上市陈倩统计显示，2024年12月，中国批准上市的新药数量为16款，其中有两款是我国自主研发的新药；美国批准8款新药上市；欧盟批准1款新药上市。

Similar to the selection of body slanting length loci, the straight line through the dorsal nail height and the vertex of the head part of the sheep was defined as straight line b, the set information ...

This was followed by Merck & Co’s Keytruda (pembrolizumab) and a gang of rival PD-L/PD-L1 checkpoint inhibitors ... And firms such as Vertex have added to the controversy with tough pricing ...